Società Takeda Pharmaceutical Company Limited

4502

JP3463000004

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per Takeda Pharmaceutical Company Limited

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
4.089 ^JPY	-0,02%		+0,49%	+0,86%

26/04	Hutchmed prende atto del parere positivo del CHMP per l'approvazione di fruiquintinib	AN
26/04	Il Comitato dell'Agenzia Europea dei Medicinali sostiene l'approvazione di fruquintinib di Takeda per il trattamento del tumore del colon-retto	MT

Takeda Pharmaceutical Company Limited è specializzata nello sviluppo, nella produzione e nella commercializzazione di prodotti farmaceutici, in particolare per le malattie metaboliche e cardiovascolari, i tumori e i disturbi del sistema nervoso centrale. L'attività è organizzata in 2 aree:
- vendita di farmaci e prodotti di consumo;
- servizi.
Le vendite nette sono distribuite geograficamente come segue: Giappone (17,5%), Asia (5%), Stati Uniti (49%), Europa e Canada (20,8%), America Latina (3,8%), Russia e CSI (1,8%) e altro (2,1%).

Numero di dipendenti: 49 095

JPY in Milioni	2022	Peso	2023	Peso	Delta
Gastrointestinal 27,2 %	875 685	24,5 %	1 094 541	27,2 %	+24,99%
Plasma Derivatives (Immune) 16,8 %	506 951	14,2 %	678 443	16,8 %	+33,83%
Neuroscience 15,8 %	482 294	13,5 %	637 711	15,8 %	+32,22%
Other 11,3 %	624 150	17,5 %	454 598	11,3 %	-27,17%
Oncology 10,9 %	468 730	13,1 %	438 742	10,9 %	-6,40%
Rare Genetic Disease and Others 10,4 %	-	-	418 724	10,4 %	-
Rare Hematology 7,6 %	283 689	7,9 %	304 718	7,6 %	+7,41%

JPY in Milioni	2022	Peso	2023	Peso	Delta
United States 52,2 %	1 714 421	48,0 %	2 103 772	52,2 %	+22,71%
Europe and Canada 20,9 %	739 168	20,7 %	842 668	20,9 %	+14,00%
Japan 12,7 %	658 983	18,5 %	512 043	12,7 %	-22,30%
Asia 5,6 %	196 964	5,5 %	225 007	5,6 %	+14,24%
Latin America 4,0 %	128 467	3,6 %	160 375	4,0 %	+24,84%
Other 2,4 %	68 945	1,9 %	95 182	2,4 %	+38,05%
Russia / Commonwealth of Independent States 2,2 %	62 057	1,7 %	88 431	2,2 %	+42,50%

Dirigenti	Titolo	Età	Da
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Gabriele Ricci CTO	Chief Tech/Sci/R&D Officer	45	01/02/22
Mwana Lugogo CMP	Compliance Officer	54	01/01/12
Michael Mendelsohn CTO	Chief Tech/Sci/R&D Officer	69	01/04/15
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Norimasa Takeda CMP	Compliance Officer	-	-
Constantine Saroukos BRD	Director/Board Member	53	01/01/15
Haruhiko Hirate IRO	Public Communications Contact	-	-
Takashi Okubo IRO	Public Communications Contact	-	-
Christopher O'Reilly IRC	Investor Relations Contact	-	01/06/11

Amministratori	Titolo	Età	Da
Yoshiaki Fujimori BRD	Director/Board Member	71	01/06/16
Ian Clark BRD	Director/Board Member	62	01/01/19
Steven Gillis BRD	Director/Board Member	71	01/01/19
John Maraganore BRD	Director/Board Member	60	01/06/22
Emiko Higashi BRD	Director/Board Member	64	01/06/16
Olivier Jean Bohuon BRD	Director/Board Member	65	08/01/19
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Constantine Saroukos BRD	Director/Board Member	53	01/01/15
Kimberly Reed BRD	Director/Board Member	53	01/06/22

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	0	1 582 418 725	1 568 419 964 ( 99,12 %)	13 486 498 ( 0,8523 %)	99,12 %

Nome	Azioni	%	Valorizzazione
BlackRock Fund Advisors 3,496 %	55 319 129	3,496 %	1 529 M ¥
BlackRock Japan Co. Ltd. 2,276 %	36 020 800	2,276 %	996 M ¥
Nikko Asset Management Co., Ltd. 2,194 %	34 711 100	2,194 %	960 M ¥
Nippon Life Insurance Co. 1,564 %	24 752 000	1,564 %	684 M ¥
Takeda Science Foundation 1,132 %	17 912 000	1,132 %	495 M ¥
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0,4747 %	7 511 300	0,4747 %	208 M ¥
Swedbank Robur Fonder AB 0,3797 %	6 008 009	0,3797 %	166 M ¥
BlackRock Investment Management (UK) Ltd. 0,3774 %	5 972 275	0,3774 %	165 M ¥
BlackRock (Netherlands) BV 0,2850 %	4 509 380	0,2850 %	125 M ¥
Takeda Pharmaceutical Employee Incentive Plan 0,2294 %	3 630 339	0,2294 %	100 M ¥

Nome	Azioni	%	Valorizzazione
Nikko Asset Management Co., Ltd. 2,762 %	87 400 834	2,762 %	1 214 M ¥
Capital Research & Management Co. (Global Investors) 0,4518 %	14 297 805	0,4518 %	199 M ¥
Mondrian Investment Partners Ltd. 0,2581 %	8 167 393	0,2581 %	113 M ¥
Millennium Management LLC 0,2052 %	6 492 911	0,2052 %	90 M ¥
Eaton Vance Management 0,1532 %	4 847 535	0,1532 %	67 M ¥
The Ayco Co. LP 0,1359 %	4 302 562	0,1359 %	60 M ¥
Renaissance Technologies LLC 0,1051 %	3 327 400	0,1051 %	46 M ¥
Brandes Investment Partners LP 0,0838 %	2 651 265	0,0838 %	37 M ¥
Wells Fargo Bank NA 0,0777 %	2 458 562	0,0777 %	34 M ¥
Macquarie Investment Management Business Trust 0,0773 %	2 445 942	0,0773 %	34 M ¥

Nome	Azioni	%	Valorizzazione
BB Gestão de Recursos DTVM SA 0,000144 %	2 276	0,000144 %	31 574 ¥

Nome	Azioni	%	Valorizzazione
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0.47%	7 511 300	0.47%	207 653 269 $
HILLEVAX, INC. 13.53%	6 724 000	13.53%	111 820 120 $
DENALI THERAPEUTICS INC. 3.03%	4 214 559	3.03%	86 482 751 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. 7.21%	2 204 000	7.21%	32 314 761 $
PHATHOM PHARMACEUTICALS, INC. 4.77%	2 790 480	4.77%	29 634 898 $
OVID THERAPEUTICS INC. 10.65%	7 531 996	10.65%	22 972 588 $
NOILE-IMMUNE BIOTECH INC. 18.76%	8 119 800	18.76%	10 086 334 $
WAVE LIFE SCIENCES LTD. 0.90%	1 096 892	0.90%	6 767 824 $
EQUILLIUM, INC. 5.23%	1 842 977	5.23%	4 257 277 $

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278 2111

http://www.takeda.co.jp

Indirizzo Takeda Pharmaceutical Company Limited(4502)

Nome	Categoria e settore
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Pharmaceuticals: Major
Takeda Pharmaceuticals International AG Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.	Pharmaceuticals: Major
Takeda Austria GmbH Takeda Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Austria GmbH engages in research and development of pharmaceutical products. The private company is based in Linz, Austria. Kirsten Detrick has been the CEO of the Austrian company since 2016.	Miscellaneous Commercial Services
Takeda GmbH Takeda GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873.	Pharmaceuticals: Major
Takeda Manufacturing Austria AG Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The private company is based in Vienna, Austria.	Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Shire Biotech India Pvt Ltd.
Shire Biotech UK Holdings Ltd. Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding private company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.	Financial Conglomerates
Takeda Belgium NV Takeda Belgium NV Medical DistributorsDistribution Services Founded in 1835, Takeda Belgium NV is a subsidiary of Takeda Pharmaceutical Co., Ltd. The private company is based in Zaventem, Belgium and focuses on providing better healthcare solutions for their patients. Takeda Belgium's mission is centered around the question of how they can do more for their patients.	Medical Distributors

Rating Trading

Rating Investimento

ESG Refinitiv

B+

Altri rating

Vendita

Buy

Raccomandazione media

Accumulate

Numero di analisti

Ultimo prezzo di chiusura

4.089 JPY

Prezzo obiettivo medio

4.779 JPY

Differenza / Target Medio

+16,88%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
TAKEDA PHARMACEUTICAL COMPANY LIMITED	+0,86%	40,76 Mrd
ELI LILLY AND COMPANY	+25,83%	661 Mrd
NOVO NORDISK A/S	+27,00%	566 Mrd
JOHNSON & JOHNSON	-6,76%	352 Mrd
MERCK & CO., INC.	+20,34%	332 Mrd
ABBVIE INC.	+3,00%	283 Mrd
ASTRAZENECA PLC	+13,09%	231 Mrd
NOVARTIS AG	+5,46%	200 Mrd
ROCHE HOLDING AG	-9,61%	195 Mrd
AMGEN INC.	-6,26%	145 Mrd

Prodotti farmaceutici - Altri